Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease-Reference-Cited by-同舟云学术

Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease

Published:2019-05-16 Issue:7 Volume:98 Page:1561-1572
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Armenis Iakovos^ORCID,Kalotychou Vassiliki,Tzanetea Revekka,Moyssakis Ioannis,Anastasopoulou Dimitra,Pantos Costas,Konstantopoulos Kostas,Rombos Ioannis

Funder

State Scholarships Foundation

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03709-8.pdf

Reference41 articles.

1. Steinberg MH (2008) Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. ScientificWorldJournal 25:1295–1324

2. Erdei J, Tóth A, Balogh E, Nyakundi BB, Bányai E, Ryffel B, Paragh G, Cordero MD, Jeney V (2018) Induction of NLRP3 inflammasome activation by heme in human endothelial cells. Oxidative Med Cell Longev 2018:4310816

3. Kanavaki I, Makrythanasis P, Lazaropoulou C, Kattamis A, Tzanetea R, Kalotychou V, Rombos I, Papassotiriou I (2012) Adhesion molecules and high-sensitivity C-reactive protein levels in patients with sickle cell beta-thalassaemia. Eur J Clin Investig 42:27–33

4. Krishnan S, Setty Y, Betal SG, Vijender V, Rao K, Dampier C, Stuart M (2010) Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. Br J Haematol 148:797–804

5. Chirico EN, Pialoux V (2012) Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMBLife 64:72–80

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of oxidative stress and anti-oxidants on the development, pathogenesis, and therapy of sickle cell disease: A comprehensive review;Biomedicine & Pharmacotherapy;2024-07

2. Genetic Basis of Sickle Cell Disease and Relevance to Pharmacoproteomics;Pharmacoproteomics;2024

3. Mitochondria: Emerging Consequential in Sickle Cell Disease;Journal of Clinical Medicine;2023-01-18

4. Stroke in sickle cell disease and the promise of recent disease modifying agents;Journal of the Neurological Sciences;2022-11

5. IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28